| Literature DB >> 30149584 |
Sunil K Deshmukh1, Manish K Gupta2, Ved Prakash3, M Sudhakara Reddy4.
Abstract
Cancer is the second leading cause of death worldwide, and the number of cases is increasing alarmingly every year. Current research focuses on the development of novel chemotherapeutic drugs derived from natural as well as synthetic sources. The abundance and diversity in natural resources offer tremendous potential for the discovery of novel molecules with unique mechanisms for cancer therapy. Mangrove-derived fungi are rich source of novel metabolites, comprising novel structure classes with diverse biological activities. Across the globe, coastal areas are primarily dominated by mangrove forests, which offer an intensely complex environment and species that mostly remain unexplored. In recent years, many structurally diverse compounds with unique skeletons have been identified from mangrove fungi and evaluated for their antiproliferative properties. These compounds may serve as lead molecules for the development of new anticancer drugs. Mangrove endophytes can be modulated using epigenetic means or culture optimization methods to improve the yield or to produce various similar analogs. The present review provides an insight into the bioactive metabolites from mangrove endophytes reported during the period from 2012 to 2018 (up to April, 2018) along with their cytotoxic properties, focusing on their chemical structures and mode of action, as indicated in the literature.Entities:
Keywords: anticancer compounds; co-culture; endophytic fungi; epigenetic modification; mangroves
Year: 2018 PMID: 30149584 PMCID: PMC6162443 DOI: 10.3390/jof4030101
Source DB: PubMed Journal: J Fungi (Basel) ISSN: 2309-608X
Figure 1Novel anticancer bioactive compounds reported from mangrove fungi.
Novel anticancer bioactive compounds reported from mangrove fungi.
| Sr. No. | Fungus | Host Plant(s) | Plant Part or Tissue Locality of Host Plants | Compounds Isolated | Cell Line | IC50/EC50/Inhibition | Refs. |
|---|---|---|---|---|---|---|---|
| Compounds Produced by | |||||||
|
|
| Not reported | Demethylincisterol A3 ( | HeLa, A549 and HepG | In the range of 0.17 to 14.16 nM | [ | |
| Ergosta-5,7,22-trien-3-ol ( | HeLa, A549 and HepG | In the range of 11.44–102.11 µM | |||||
|
|
|
| Cameroon | Compound ( | L5178Y | 0.7, 5.6, 3.4, and 3.9 µM | [ |
| Pestalotioprolide E ( | A2780 | 1.2 µM | |||||
|
|
|
| Port Harcourt, Nigeria | Pestalpolyol I ( | L5178Y | 4.10 µM | [ |
|
|
|
| China | Pestalamine A ( | MCF-7, HeLa, and HepG2 | 40.3, 22.0, and 32.8 µM | [ |
|
| Fruit sample of | Wenchang, Hainan Province, China | Phomazines B ( | HL-60, HCT-116, K562, MGC-803, and A549 Cells | In the range 0.05 to 8.5 µM | [ | |
|
| Zhanjiang, China | Cytochalasin H ( | A549 cells | Arrested A549 cells at the G2/M phase, inhibited the migration ability of A549 cells in a dose-dependent manner | [ | ||
|
| Leaves | Trang Province, Thailand | Phomopsichalasin G ( | HCT-8, HCT-8/T, A549, MDA-MB-231, and A2780 cancer Cells | 7.5, 8.6, 6.4, 3.4, and 7.1 µM | [ | |
|
| 6-aminopurine-9-carboxylic acid Me ester ( | B16F10, A549, HL-60 and MCF-7 Cells | 14.9 and 8.6 µM | [ | |||
|
| Branch of | South China Sea, Hainan province, China | Dicerandrol A ( | MDA-MB-435, HCT-116, Calu-3 and Huh7 Cells | 3.03, 2.64, 1.76 and 4.19 µM | [ | |
| Dicerandrol B ( | MDA-MB-435, HCT-116 and Calu-3 | <10 µM | |||||
| Dicerandrol C ( | MDA-MB-435, HCT-116, Calu-3, MCF-10A Cells | 44.10, 42.63, 36.52, and 33.05 µM | |||||
| diacetyl phomoxanthone B ( | MDA-MB-435, HCT-116, Calu-3, Huh7 Cells | 14.40, 7.12, 4.14 and 29.20 µM | |||||
|
|
| Dong Sai, South China Sea coast | 3- | HEp-2 and HepG2 | 9 and 16 µM | [ | |
|
|
| Sanya city, Hainan Province, China | Isochromophilone D ( | 786-O cells | 8.9 µM | [ | |
| epi-Isochromophilone II ( | ACHN, OS-RC-2, and 786-O cells, | In the range of 3.0 to 4.4 µM, Sorafenib (3.4 to 7.0 µM) | |||||
|
| Branches of | Shankou, Guangxi province, China | 5-deoxybostrycoidin ( | MDA-MB-435 and NCI-H460 cancer cells | 5.32 and 6.57 µM | [ | |
| Fusaristatin A ( | MDA-MB-435 cancer cells | 8.15 µM | |||||
|
| Foliage of | Fujian Province, China | Mycoepoxydiene ( | MDA-MB-435 | 7.85 and 14.61 µM, | [ | |
|
| Foliage of | Fujian Province, China | Mycoepoxydiene ( | Suppress antigen-stimulated degranulation and cytokine production in mast cells and IgE-mediated passive cutaneous anaphylaxis in mice | [ | ||
| Compounds Produced by | |||||||
|
| rhizosphere soil of | Guangxi Province, China | Saroclazine B ( | HeLa Cells | 4.2 µM | [ | |
|
|
| Cameroon | Daldinone I ( | Ramos and Jurkat J16 | 6.6 and 14.1 µM, Potently blocks autophagy, a potential pro-survival pathway for cancer cells | [ | |
|
|
|
| “BoHai” seaside, China | Rubrumol ( | A549, MDA-MB-231, PANC-1 and HepG2 | Cytotoxic | [ |
| Topo I | Relaxation activity The band backward shifting and trailing of rubrumol (36) was observed at 100, 50, 10, 5 and 1 µM | ||||||
|
| Soil of mangrove rhizosphere in Jimei, Fujian Province, China | Not reported | 13-Hydroxy-3,8,7(11)-eudesmatrien-12,8-olide ( | JEKO-1 and HepG2 | 8.4 and 28.5 µM | [ | |
|
| Leaves of | Samutsakhon province, Thailand | Rhytidenones G ( | Ramos lymphoma | 17.98, 0.018, 18.00, 33.1, 15, 82.9, 0.461, 0.048, 31.7 and 23.1 µM, (Ibrutinib 28.7 µM) | [ | |
| Compounds ( | H1975 Cell | 7.3, 0.252, 10.24, 1.17 and 50 µM (afatinib 1.97 µM) | |||||
|
|
| Guangdong Province, China | 2,4-Dihydroxy-6-nonylbenzoate ( | MMQ and GH3 Cells | 5.2 and 13.0 µM | [ | |
|
|
| Guangdong Province, China | Ethyl-2,4-dihydroxy-6-(80-hydroxynonyl)-benzoate ( | MDA-MB-435, HepG2, HCT-116, A549 and leukaemia THP1 Cells | 0.13, 12.50, 11.92, 13.31 and 39.74 µM | [ | |
|
|
| Guangdong Province, China | Chloropreussomerins A and B ( | A549 and MCF-7 | In the range of 5.9–8.9 µM | [ | |
| Preussomerin K ( | A549, HepG2, MCF-7 | In the range of 2.5–9.4 µM | |||||
|
| Leaves of | Pak Nam Pran, Prachuab Kiri Khan Province, Thailand | Rhytidchromone A ( | Kato-3 Cells | In the range of 16.0–23.3 µM | [ | |
| MCF-7 cells | 19.3–17.7 µM | ||||||
|
| Root of | China | Campyridone D ( | HeLa | 8.8 and 4.7 µM | [ | |
|
|
|
| Hurghada, Egypt | Dihydroaltersolanol C ( | L5178Y | 3.4, 2.53, 3.78 and 6.9 µM | [ |
| Altersolanol N ( | L5178Y | Low micromolar range (% growth-1.4) | |||||
|
| Associated with mangrove wood | Laem SonNational Park, Ranong Province, Thailand | Paradictyoarthrins A ( | KB, MCF-7, NCI-H187, Vero Cells, KB, MCF-7, NCI-H187, Vero Cells | In the range of 23–31 µg/mL | [ | |
| Paradictyoarthrin B ( | KB, MCF-7, NCI-H187, Vero Cells | 3.1, 3.8, 9.5, and 5.6 µg/mL | |||||
| Preussomerin C ( | KB, MCF-7, NCI-H187, Vero Cells | Moderate to poor activity | |||||
| ymf 1029C ( | NCI-H187 cells | 5.0 µg/mL | |||||
|
| -- | South China Sea | SZ-685C ( | NFPA, MMQ and RPC cells | 18.76, 14.51, and 56.09 µM | [ | |
|
|
| Fujian Province, China | Dothiorelone F ( | Raji cancer | 2 µg/mL | [ | |
|
| Leaves of | Samutsakhon province, Thailand | Rhytidones B–C ( | MCF-7 and CaSki Cells | In the range of 14.47 and 25.59 µM | [ | |
| Rhytidones B ( | CaSki | 22.81 µM | |||||
|
| Bark, | South China Sea | Sporothrin A ( | Inhibition of AChE in vitro | 1.05 µM | [ | |
| sporothrin B ( | HepG2 | 20, 23, and 23 µg/mL | |||||
|
|
| Semi-mangrove plant | Hainan Island, China | 12-demethyl-12-oxo-eurotechinulin B ( | HepG2, MCF-7, SW1990, HepG2, NCI-H460, SMMC7721, HeLa, and Du145 | In the range of 15–30 µg/mL | [ |
|
|
| Inner leaf tissues of the plant | Hainan island, China | Pullularins E ( | L5178Y | EC50 values In the range of 0.1 and 6.7 µg/mL | [ |
| verticillin D ( | L5178Y | <0.1 µg/mL | |||||
|
| Leaves, | Hainan Island, China | Aspergisocoumrins A–B ( | MDA-MB-435 | 5.08 and 4.98 µM | [ | |
|
|
| Hainan, China | Nigerasterol A ( | HL60 | 0.30 µM, 1.50 µM | [ | |
| Nigerasterol A ( | A549 | 1.82 and 5.41 µM | |||||
|
| Leaves, | Aniquinazolines A–D ( | Brine shrimp | LD50 1.27, 2.11, 4.95 and 3.42 µM, (Colchicine LD50 88.4 µM | [ | ||
|
| Branch of | South China Sea | 3β,5α-dihydroxy-(22 | MCF-7, A549, HeLa and KB | 4.98 and 2.02, 1.95 and 0.82, 0.68 and 1.14, 1.50 and 1.10 µM | [ | |
| 3β,5α,14α-trihydroxy-(22 | MCF-7, A549, HeLa and KB | 25.4, 27.1, 24.4, 19.4 µM | |||||
|
| Branch of | South China Sea | Botryosphaerin F ( | MCF-7 and HL-60 | 4.49 and 3.43 µM | [ | |
| HL-60 | 0.6 µM | ||||||
|
| Leaves, | Hainan province, China | Penicieudesmol B ( | K-562 | 90.1 µM, (paclitaxel, 9.5 µM) | [ | |
|
| South China Sea | Penibenzophenone B ( | A549 Cells | 15.7 µg/mL | [ | ||
|
|
| Wenshan, Yunnan province, China | Brefeldin A ( | 293, HepG2, Huh7 and KB cell line | LD50 value from 0.024 to 0.62 µM. Both the compounds arrested HepG2 cells at the S phase | [ | |
|
| Vein of | Leizhou Peninsula, China | Penochalasin K ( | MDA-MB-435, SGC-7901 and A549 cells | <10 µM | [ | |
|
|
| Hainan Province, China | Penicisulfuranols A–C ( | HeLa and HL-60 Cells | In the range of 0.1 to 3.9 µM | [ | |
|
| Not reported | Not reported | Penochalasin I ( | MDA-MB-435 and SGC-7901 cells | <10 µM | [ | |
| Compounds ( | SGC-7901 and A549 cells | <10 μM | |||||
|
| Mangrove plant | Hainan Island, China | Spirobrocazine C ( | A2780 | 59 µM | [ | |
| Brocazine G ( | A2780 and A2780 CisR | 664 nM, 661 nM (cisplatin 1.67 and 12.63 µM) | |||||
|
| Mangrove plant | Hainan Island, China | Brocazines A ( | Du145, Hela, HepG2, MCF-7, NCI-H460, SGC-7901, SW1990, SW480, and U251 | from 0.89 to 9.0 µM | [ | |
| Compounds ( | SW480 tumor cell line | 2.0 and 1.2 µM | |||||
| Compound ( | DU145 and NCI-H460 Cells, | 1.7 and 0.89 µM | |||||
|
| Samut Sakhon province, Thailand | TMC-264 ( | T47D and MDA-MB231 | 1.08 and 2.81 µM (doxorubicin 1.55 and 2.24 µM) | [ | ||
| HepG2 | 3.27 µM (Etoposide, 35.66 µM) | ||||||
| MOLT-3 | 1.36 µM | ||||||
| T47D | 1.08 µM | ||||||
| PR-toxin ( | HuCCA-1, HeLa, T47D, and MDA-MB231 | 0.81–2.19 µM (doxorubicin, 0.26–2.24 µM) | |||||
| HL-60 cell line | 0.06 µM (doxorubicin, 1.21 µM) | ||||||
| MOLT-3 and HL-60 | 0.09 µM, 0.06 µM | ||||||
|
| The rhizosphere soil of the mangrove plant | China | Penicitols A ( | HeLa, BEL-7402, HEK-293, HCT-116, and A549 Cells | 4.6−10.5 µM | [ | |
| Penicitols B ( | 3.4−9.6 µM | ||||||
| Penicitols C ( | In the range of 10–40.5 µM | ||||||
|
|
| Fujian, China | Compound ( | Tca8113 and MG-63 cells | 26 and 35 µM (Taxol, 46 and 10 nM) | [ | |
| Compounds ( | Tca8113 and WRL-68 | 10 and 58 µM | |||||
| Compounds ( | MG-63 cells | 55 nM | |||||
|
|
| Zhanjiang, China | Meleagrin ( | HL60 and A549 | 9.7 and 8.3 µM | [ | |
|
| Sea water | Guangdong Province, China | 5S, 7R, 9S, 10S, 11R, 12S, 13R, 22R, and 23R. ( | MDA-MB-435, HepG2, HCT-116, and A549 | In the range of 11.9–37.82 µg/mL | [ | |
| Compounds ( | MDA-MB-435 | 7.13 | |||||
| Compound ( | HepG2 and HCT-116 | 39.64 and 27.80 µM | |||||
|
| Leaves, | Dong Sai, Hainan of the South China Sea coast | 4-(methoxymethyl)-7-methoxy-6-methyl-1(3 | KB and KBV200 cells | 6 and 10 µg/mL | [ | |
|
| Rhizosphere, | WenChang in Hainan Island, China | Sumalarins A–C ( | Du145, HeLa, Huh 7, MCF-7, NCI-H460, SGC-7901, and SW1990 Cells | In the range of 3.8 to 10 µM | [ | |
|
| South China Sea | 5-methyl-8-(3-methylbut-2-enyl) furanocoumarin ( | KB and KBV200 | 5 and 10 µg/mL | [ | ||
|
| Stem bark, | Guangdong Province, China | (3 | GH3 and MMQ Cells RPC | 21.42 and 13.59 µM, 142.8 µM | [ | |
| Co cultured with | (3 | 6.44 and 6.58 µM, 6.94 µM | |||||
| (3 | 12.33 and 10.13 µM, 100.03 µM. | ||||||
|
| Stem bark of | Guangdong Province, China | Botryorhodine H ( | MMQ GH3 Cells | 3.09 and 3.64 µM | [ | |
|
| Leaves, stems and peels of | Hainan province, China | (9 | HeLa and MCF-7 Cells | 30.1 µM and 30.7 µM | [ | |
|
|
| Guangxi Zhuang Autonomous Region of China | 2,3-didehydro-19α-hydroxy-14-epicochlioquinone B ( | MCF-7, SW1990, and SMMC7721 | 4, 5, and 7 µg/mL | [ | |
|
| Bark of | Dongzhai mangrove, Hainan, China | Beauvericin ( | KB and KBv200 cells | 5.76 and 5.34 µM | [ | |
|
| Leaf of mangrove | Dongzhai Harbor of Hainan Island, China | Apicidin ( | GLC-82 cells | 6.94 µM | [ | |
|
| Unidentified fungus ZZF42 | South China Sea | Not reported | Apicidin ( | KB and KBv200 | 0.78 µg/mL | [ |
|
|
| Not reported | 2-acetyl-1,2,3,4-tetrahydro-β-carboline ( | HUVEC and K-562 | GI50 41.1 and 33.3 | [ | |
| HeLa cell | CC50 23.8 µM | ||||||
|
| Not reported | Fusamine ( | HUVEC and K-562 | GI50 37.3 and 37.6 | [ | ||
| HeLa cell | CC50 23.3 µM | ||||||
|
| Not reported | 3-(1-aminoethylidene)-6-methyl-2 | HUVEC and K-562 | GI50 41.1 and 33.3 | [ | ||
| HeLa cell | CC50 23.8 µM | ||||||
|
| leaves of | Dong Zhai Gang Mangrove Garden, Hainan, China | Torrubiellin B ( | Cisplatin sensitive Cal27, Kyse510, HCC38, A2780, MDA-MB-231 | In the range of 0.3 to 1.5 µM | [ | |
| Cisplatin resistant, Cal27, Kyse510, HCC38, A2780, MDA-MB-231 | In the range of 0.2 to 2.6 µM | ||||||
|
|
|
| Island of Cat Ba, Vietnam | Waol A ( | Cisplatin-sensitive, A2780 | 27.1, 76.2, and 8.3 µM | [ |
| Cisplatin-Resistant A2780 | 12.6, 30.1, and 19.0 µM | ||||||
|
| Endophytic fungus J3 |
| Hainan province, China | 3,4-seco-sonderianol ( | K562, SGC-7901, and BEL-7402 Cells | 9.2, 15.7, and 25.4 µg/mL | [ |
|
| Endophytic fungus No. ZH-3 | Not reported | South China Sea | 2-(3-chloro-2, 6-dihydroxy-4-methylbenzoyl)-5-hydroxy-3-methoxybenzoate ( | HepG2 cell line | 25 µg/mL | [ |
|
| Endophytic fungus No. 5094 | Not reported | South China Sea | Anthracene derivative ( | KB and KBv200 | LD50 values of 5.5 and 10.2 µM | [ |
|
| Co-cultures of two mangrove endophytic fungi (strains Nos. 1924 and 3893) | Not reported | Marinamide ( | HepG2, 95-D, MGC832 and HeLa Cells | 7.0, 0.4, 91 nM and 0.529 µM | [ | |
| Methyl marinamide ( | HepG2, 95-D, MGC832 and HeLa Cells | 2.52, 1.54 13, 0.110 µM | |||||
|
| Endophytic fungus No·Gx-3a | Not reported | South China sea | Ditryptophenaline ( | KB, KBv200 | 8.0 and 12.0 µM | [ |
|
| Mangrove endophytic fungus No·SK7RN3G1 | Not reported | South China Sea | 3,8-dihydroxy-6-methyl-9-oxo-9 | HepG2 cell line | 20 and 25 µg/mL | [ |
| Compounds Produced by | |||||||
|
| Basidiomycetous fungus XG8D | leaves of | Samutsakorn province, Thailand | Merulinols C and D ( | KATO-3 cells | 35.0 and 25.3 µM | [ |
|
|
| Samut Sakhon province, Thailand | Compound ( | HuCCA-1, A549, MOLT-3, HepG2, MDA-MB231, T47D | 0.28–37.46 µM | [ | |
| MRC-5 | IC50 17.92 µM | ||||||
| HL-60 cell line | IC50 0.28 µM | ||||||
| Compound ( | A549, MOLT-3, HepG2, HL-60, MDA-MB231, T47D, HeLa cancer cell, MRC-5 | 12.09–170.08 µM | |||||
| Compound ( | HuCCA-1, A549, MOLT-3, HepG2, HL-60, MDA-MB231, T47D, HeLa cancer cell | 15.20–76.97 µM | |||||
| Compound ( | HuCCA-1, A549, MOLT-3, HepG2, MDA-MB231, T47D, HeLa cancer cell | 18.31–154.51 µM | |||||
| HL-60 | 18.31 µM | ||||||
|
|
|
| Not reported | Endoperoxide ( | MOLT-3, HuCCA-1, A549, HepG2, HL-60, MDA-MB-231, T47D, and HeLa cancer Cells | In the range of 0.68–3.71 and 0.67–5.25 µg/mL | [ |
| Merulin B ( | MOLT-3, A549, HepG2, HL-60, MDA-MB-231 and T47D Cells | In the range of 11.94–49.08 µg/mL | |||||
| Merulin C ( | HL60 cancer cells | 0.08 µg/mL | |||||
| MOLT-3, HuCCA-1, A549, HepG2, MDA-MB-231, T47D, and HeLa Cells | In the range of 0.19–3.75 µg/mL | ||||||
|
|
| Hainan Island, China | Rhizovarins A, B, E ( | A-549 | 11.5, 6.3, 9.2, 8.4, 8.0, 8.2 and 4.6 µM | [ | |
| Rhizovarins A, B, ( | HL-60 | 9.6, 5.0, 7.0, 4.7, 3.3 and 2.6 µM | |||||
Figure 2Structures of metabolites isolated from Coelomycetes (1–22).
Figure 3Structures of metabolites isolated from Coelomycetes (23–33) and Ascomycetes (34–46).
Figure 4Structures of metabolites isolated from Ascomycetes (47–67).
Figure 5Structures of metabolites isolated from Ascomycetes (68–90).
Figure 6Structures of metabolites isolated from Ascomycetes (91–93) and Hyphomycetes (94–107).
Figure 7Structures of metabolites isolated from Hyphomycetes (108–130).
Figure 8Structures of metabolites isolated from Hyphomycetes (131–149).
Figure 9Structures of metabolites isolated from Hyphomycetes (150–170).
Figure 10Structures of metabolites isolated from Basidiomycetes (171–174) and from Zygomycetes (175–181).